Marcelo Kugelmas

6.5k total citations · 1 hit paper
47 papers, 2.6k citations indexed

About

Marcelo Kugelmas is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Marcelo Kugelmas has authored 47 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hepatology, 28 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in Marcelo Kugelmas's work include Liver Disease Diagnosis and Treatment (26 papers), Hepatitis C virus research (20 papers) and Liver Disease and Transplantation (14 papers). Marcelo Kugelmas is often cited by papers focused on Liver Disease Diagnosis and Treatment (26 papers), Hepatitis C virus research (20 papers) and Liver Disease and Transplantation (14 papers). Marcelo Kugelmas collaborates with scholars based in United States, United Kingdom and Belgium. Marcelo Kugelmas's co-authors include Craig J. McClain, Daniell B. Hill, James F. Trotter, Luis Marsano, Gregory T. Everson, Shirish Barve, Ion V. Deaciuc, Lisa Forman, Michael Wachs and Igal Kam and has published in prestigious journals such as The Lancet, Gastroenterology and Hepatology.

In The Last Decade

Marcelo Kugelmas

46 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

2018 344 citations Manal F. Abdelmalek, James F. Trotter et al. profile →

Peers

Countries citing papers authored by Marcelo Kugelmas

Since Specialization

Citations

This map shows the geographic impact of Marcelo Kugelmas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcelo Kugelmas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcelo Kugelmas more than expected).

Fields of papers citing papers by Marcelo Kugelmas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcelo Kugelmas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcelo Kugelmas. The network helps show where Marcelo Kugelmas may publish in the future.

Co-authorship network of co-authors of Marcelo Kugelmas

This figure shows the co-authorship network connecting the top 25 collaborators of Marcelo Kugelmas. A scholar is included among the top collaborators of Marcelo Kugelmas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcelo Kugelmas. Marcelo Kugelmas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The use of current knowledge and non‐invasive testing modalities for predicting at‐risk non‐alcoholic steatohepatitis and assessing fibrosis 2023 ·Liver International ·Marcelo Kugelmas, Mazen Noureddin, Nadege Gunn, Kimberly Brown, Zobair M. Younossi, Manal F. Abdelmalek, Naim Alkhouri	12
2	Expert perspectives for the pharmacist on facilitating and improving the use of albumin in cirrhosis 2023 ·American Journal of Health-System Pharmacy ·Marcelo Kugelmas, (unknown), (unknown), Hani M. Wadei, Sammy Saab	3
3	Treatment Options for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing a Scheduled Procedure 2020 ·Journal of Clinical Gastroenterology ·Sammy Saab, David Bernstein, Tarek Hassanein, Marcelo Kugelmas, Paul Y. Kwo	7
4	Diagnosis of pancreatic duct-portal vein fistula; a case report and review of the literature 2014 ·Journal of Radiology Case Reports ·Anthony Brown, Eric S. Malden, Marcelo Kugelmas, (unknown)	16
5	African Americans Are Less Likely to Have Clearance of Hepatitis C Virus Infection 2011 ·Journal of Clinical Gastroenterology ·(unknown), Maria Stepanova, Mariam Afendy, Marcelo Kugelmas, Zobair M. Younossi	13
6	Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy† 2005 ·Hepatology ·Gregory T. Everson, James F. Trotter, Lisa Forman, Marcelo Kugelmas, (unknown), Barbara Fey, (unknown)	241
7	Using pegylated interferon and ribavirin to treat patients with chronic hepatitis C. 2005 ·PubMed ·Raymond P. Ward, Marcelo Kugelmas	42
8	Management of hepatitis C: evaluating suitability for drug therapy. 2004 ·PubMed ·Raymond P. Ward, Marcelo Kugelmas, (unknown)	11
9	Liver Biopsy 2004 ·The American Journal of Gastroenterology ·Marcelo Kugelmas	8
10	Hepatic Artery Chemoembolization for Hepatocellular Carcinoma in Patients Listed for Liver Transplantation 2004 ·American Journal of Transplantation ·Paul H. Hayashi, (unknown), Lisa Forman, Michael J. Osgood, (unknown), Marcelo Kugelmas, James F. Trotter, Thomas H. Bak, Michael Wachs, Igal Kam, Janette D. Durham, Gregory T. Everson	65
11	Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD 2004 ·Liver Transplantation ·Paul H. Hayashi, James F. Trotter, Lisa Forman, Marcelo Kugelmas, Tracy Steinberg, Paul Russ, Michael Wachs, Thomas H. Bak, Igal Kam, Gregory T. Everson	74
12	Treatment of Budd‐Chiari syndrome in a Liver Transplant Unit, the role of transjugular intrahepatic porto‐systemic shunt and liver transplantation 2004 ·Alimentary Pharmacology & Therapeutics ·Augustin Attwell, (unknown), Russell Nash, Marcelo Kugelmas	36
13	Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation 2003 ·Liver Transplantation ·Marcelo Kugelmas, (unknown), Michael J. Osgood, David A. Young, James F. Trotter, Tracy Steinberg, Michael Wachs, Thomas H. Bak, Igal Kam, Gregory T. Everson	87
14	Cytokines and Nash: A Pilot Study of the Effects of Lifestyle Modification and Vitamin E 2003 ·Hepatology ·Marcelo Kugelmas, Daniell B. Hill, (unknown), Luis Marsano, Craig J. McClain	428
15	Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection 2003 ·Liver Transplantation ·Marcelo Kugelmas, Michael J. Osgood, James F. Trotter, Thomas H. Bak, Michael Wachs, Lisa Forman, Igal Kam, Gregory T. Everson	46
16	Chronic mucoid Pseudomonas aeruginosa cholangitis complicating ERCP in a CF patient 2002 ·Journal of Cystic Fibrosis ·(unknown), Matthew Dickinson, David S. James, Marcelo Kugelmas, Nancy Madinger, David M. Rodman	2
17	Right hepatic lobe donation for living donor liver transplantation: Impact on donor quality of life 2001 ·Liver Transplantation ·James F. Trotter, Michael Talamantes, (unknown), Michael Wachs, Thomas H. Bak, T Trouillot, Marcelo Kugelmas, Gregory T. Everson, Igal Kam	179
18	Preliminary Observation: Oral Zinc Sulfate Replacement is Effective in Treating Muscle Cramps in Cirrhotic Patients 2000 ·Journal of the American College of Nutrition ·Marcelo Kugelmas	37
19	Cytokines in Alcoholic Liver Disease 1999 ·Seminars in Liver Disease ·Craig J. McClain, Shirish Barve, Ion V. Deaciuc, Marcelo Kugelmas, Daniell B. Hill	327
20	Nontraumatic Abdominal Pain 1997 ·AACN Clinical Issues Advanced Practice in Acute & Critical Care ·(unknown), Marcelo Kugelmas	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact